Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Read more

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Read more

Complete Spinal Cord Injury

We are developing an innovative treatment that aims to improve the patients’ quality of life.

Read more

Press releases

• August 14, 2018Invitation to presentation of BioArctic’s Interim Report for the period January – June 2018 on August 23, 2018
• August 7, 2018BioArctic obtains exclusive rights to develop antibody treatments for Alzheimer’s disease from a research project jointly owned with Eisai
• July 25, 2018BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer’s disease presented at AAIC 2018

Archive

Interim Report January – June 2018

BioArctic AB published the company’s Interim Report January – June 2018 on Thursday, August 23.

• Invitation
• Webcast

Read the invitation

Calendar

• August 23, 2018Interim Report January – June 2018
• August 24, 2018Gunilla Osswald, CEO, presents BioArctic at the Swedish American Life Science Summit 2018, Stockholm, Sweden
• November 8, 2018Interim Report January – September 2018

All events